Housaiyin Li

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “683 CD8 T cell repertoire analysis of patients with resectable head and neck cancer enrolled in a phase II neoadjuvant study of α-PD1 administered alone or in combination with α-CTLA4 or α-LAG3”.

683 CD8 T cell repertoire analysis of patients with resectable head and neck cancer enrolled in a phase II neoadjuvant study of α-PD1 administered alone or in combination with α-CTLA4 or α-LAG3

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0683

N/A

0DataRank · unranked

2 citations

Aditi Kulkarni, Housaiyin Li, Jie Chen, Lazar Vujanović, Seungwon Kim +4 more

490 Galectin-9 drives TIM-3+ natural killer cell dysfunction in head and neck squamous cell carcinoma

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0490

N/A

0DataRank · unranked

1 citations

Juncheng Wang, Housaiyin Li, Aditi Kulkarni, Jennifer Anderson, Lídia Maria Rebolho Batista Arantes +7 more

1037 Single cell evaluation of antigen specificity, clonal dynamics and transcriptional signatures of CD8+ T cells in head and neck squamous carcinoma

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.1037

N/A

0DataRank · unranked

0 citations

Patrícia Santos, Aditi Kulkarni, Alok V. Joglekar, Lazar Vujanović, Robert L. Ferris +1 more

Neoadjuvant nivolumab alone or in combination with relatlimab or ipilimumab in resectable head and neck squamous cell carcinoma (HNSCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6018

N/A

0DataRank · unranked

17 citations

William E. Gooding, Simion I. Chiosea, Umamaheswar Duvvuri, Seungwon Kim, Mark Kubik +8 more

1003 TIM-3+ natural killer cell dysfunction is driven by galectin-9 in head and neck squamous cell carcinoma

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.1003

N/A

0DataRank · unranked

0 citations

Housaiyin Li, Aditi Kulkarni, Jennifer Anderson, Lídia Maria Rebolho Batista Arantes, Hridesh Banerjee +7 more

547 Reprogramming of type I interferon-responding tumor-reactive T lymphocytes associates with improved outcomes to neoadjuvant doublet immunotherapy in HNSCC

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0547

N/A

0DataRank · unranked

0 citations

P.M.L. Santos, Aditi Kulkarni, Brian R. Isett, Joy Marion, Simion I. Chiosea +8 more

Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies

Cancer Cell(2025)10.1016/j.ccell.2025.02.026

N/A

0DataRank · unranked

61 citations

Dan P. Zandberg, Aditi Kulkarni, Simion I. Chiosea, Patricia M. Santos, Brian R. Isett +19 more

Differential impact of TIM-3 ligands on NK cell function

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010618

N/A

0DataRank · unranked

20 citations

Housaiyin Li, Aditi Kulkarni, Jennifer L. Anderson, Pragati Upadhyay, Onyedikachi Victor Onyekachi +9 more